Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2001
12/20/2001WO2001096296A1 Serine protease inhibitors
12/20/2001WO2001095933A2 Immunization through oral administration of a vaccine with an edible product
12/20/2001WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001WO2001095921A1 Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials
12/20/2001WO2001095916A2 Anticholestatic medicament containing luteolin-7-o-glucuronide
12/20/2001WO2001095912A1 COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
12/20/2001WO2001095911A1 Protease inhibitors
12/20/2001WO2001095893A1 Use of an epoxy-steroidal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
12/20/2001WO2001095892A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
12/20/2001WO2001095886A1 Bioavailable dosage form of isotretinoin
12/20/2001WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds
12/20/2001WO2001095785A2 Modulation of immune response and methods based thereon
12/20/2001WO2001095746A1 Compositions for taking dietary fibers
12/20/2001WO2001088108A8 Neuronal serine-threonine protein kinase
12/20/2001WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents
12/20/2001WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001WO2001052816A3 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
12/20/2001WO2001052796A3 Methods of using a beverage composition for treating dental erosion
12/20/2001WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001WO2001044207A3 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
12/20/2001WO2001015693A3 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
12/20/2001WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/20/2001US20010053788 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
12/20/2001US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001US20010053764 Interleukin-1 inhibitors in the treatment of diseases
12/20/2001US20010053763 Method and composition for modulating an immune response
12/20/2001US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001US20010053351 Inhibition of GSK-3 beta
12/20/2001DE10029047A1 Treating or preventing intrahepatic cholestasis and regulating cholesterol formation, using luteolin-7-O-glucuronide to combat intrahepatic changes in the bile ducts
12/20/2001DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase
12/20/2001CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001CA2412353A1 Protease inhibitors
12/20/2001CA2412343A1 Immunization through oral administration of a vaccine with an edible product
12/20/2001CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001CA2411805A1 Serine protease inhibitors
12/20/2001CA2411798A1 Serine protease inhibitors
12/20/2001CA2411472A1 Cd154 variants
12/20/2001CA2410610A1 Human kinases
12/20/2001CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
12/20/2001CA2409315A1 Protein phosphatases
12/20/2001CA2407699A1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
12/20/2001CA2382065A1 Bioavailable dosage form of isotretinoin
12/19/2001EP1164132A2 Crystalline magnesium omeprazole
12/19/2001EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001EP1163267A1 47 human secreted proteins
12/19/2001EP1163255A1 50 human secreted proteins
12/19/2001EP1163243A2 Calanolides for inhibiting btk
12/19/2001EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001EP1163237A1 Amide derivatives
12/19/2001EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists
12/19/2001EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001EP1163212A1 Amide derivatives
12/19/2001EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001EP1163204A1 Lipoxin compounds and their use
12/19/2001EP1162990A1 Treatment with small peptides to effect antifibrotic activity
12/19/2001EP1162987A1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
12/19/2001EP1162986A1 Lactobacillus strains preventing diarrhoea caused pathogenic bacteria
12/19/2001EP1162970A2 Anti-inflammatory uses of manzamines
12/19/2001EP1162884A1 Oral low dose butyrate compositions
12/19/2001EP1053743B1 Composition for the treatment of halitosis
12/19/2001EP1001990A4 Protein that binds trail
12/19/2001EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001EP0746624B1 Vector for liver-specific gene expression
12/19/2001EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors
12/19/2001CN1327452A Fibroblast growth factor with hepatocyte proliferation activity
12/19/2001CN1327389A Coupling factor 6 inhibitor and potentiator and use thereof
12/19/2001CN1327382A Improved formulation for topical non-invasive application in vivo
12/19/2001CN1326947A Human thymosin alpha protogene mutant synthesis, expression and use
12/19/2001CN1326782A About human digestive enzyme recombined protein and its preparing method
12/19/2001CN1326779A Chunren liver recovering capsule
12/19/2001CN1326775A Chinese medicine granule for treating lithiasis and its preparing method
12/19/2001CN1326774A Compound brain nourishing liquid and its preparing method
12/19/2001CN1326768A Shiweier antidiarrheic
12/19/2001CN1326763A Pure Chinese medicine prepn. for fast strengthening yang and tonifying kidney
12/19/2001CN1326760A Chinese patent medicine for regulating function of liver and spleen
12/19/2001CN1326759A Natural medicine intestine cleaning liquid and use of health tea
12/19/2001CN1326755A Life prolonging detoxicating powder
12/19/2001CN1326746A Montmorilonite as component of animal medicine and fodder additive
12/19/2001CN1326745A Montmorillonite as component of gastrointestinal tract medicine
12/19/2001CN1326744A New use of polyunsaturated lecithin
12/19/2001CN1326705A Intestine cleaning water and producing method
12/19/2001CN1076352C 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agaonists
12/19/2001CN1076200C Medicine for curing cardiovascular diseases
12/19/2001CN1076195C Compound containing zinc and composition of p-acetaminophenyl acetic acid
12/19/2001CA2350857A1 The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
12/18/2001US6331631 Reacting 4-piperidinocarboxamide and 1-bromobutane, reduction with lithium aluminum hydride using toluene as solvent
12/18/2001US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis
1 ... 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 ... 1258